What Would You Do in the Event of Contamination?- An Interview with Lada Laenen

Hosted By: Gerald Clarke
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

In 2008 and 2009, Genzyme sites were affected by vesivirus infection. This shut down two sites for decontamination. In this candid interview, Lada Laenen, Managing Principal Scientist, Head, Cell Culture and Microbiology, Genzyme, a Sanofi Company, discusses how this affected Genzyme.  She explains what they have changed to avoid this happening again. Dr. Laenen also describes the company's creation of an 'organisms of concern' list, ensuring quality in raw materials and what's holding back the use of new technologies for pathogen detection.


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018